AVAI · Avai Bio, Inc.
$0.12
+0.01 (+4.44%)
At close · Sep 2
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Therefore, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$18.09M
Shares
153.92M
AVAI metrics
45 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.12
Market cap
$18.09M
Price action
19 metricsPrice change (1W)
-2.2%
Price change (30D)
-10.7%
Price change (3M)
-36.8%
Price change (6M)
-71.7%
Price change (YTD)
-70.4%
Price change (1Y)
-72.6%
Trailing year
Price change (5Y)
-95.4%
52-week high
$0.78
52-week low
$0.11
Change from 52-week high
-85.5%
Change from 52-week low
+0.0%
Annualized volatility
125.9%
Beta
1.1
RSI (14D)
43.1
Price vs SMA 50
-18.9%
Price vs SMA 200
-62.7%
Avg volume (3M)
121,003
Relative volume
0.6
Average dollar volume
$17,969
Company
3 metricsSector
Technology
Industry
Software - Application
Shares outstanding
153.92M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-15.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
-14.6%
Operating margin
-126.3%
Trailing 12 months
Net margin
-126.3%
Gross profit (TTM)
−$40,453
Operating profit (TTM)
−$2.79M
Net income (TTM)
−$2.79M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
-213.2%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-352.3%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$83,586
Total assets
$791,750
Total debt
$24,918
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$1.18M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
22 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged